Mirae Asset Global Investments Co., Ltd. Arrowhead Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $24 Billion
- Q4 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 4,147 shares of ARWR stock, worth $61,375. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,147
Previous 4,496
7.76%
Holding current value
$61,375
Previous $87,000
11.49%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding ARWR
# of Institutions
304Shares Held
95.8MCall Options Held
523KPut Options Held
493K-
Black Rock Inc. New York, NY15.7MShares$232 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$180 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$164 Million3.04% of portfolio
-
State Street Corp Boston, MA6.02MShares$89 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$77.4 Million1.89% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $1.57B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...